SARAF and cardiac hypertrophy: Indeed, consistent with the results of our study, a very recent study on mice with cardiac hypertrophy showed that higher Ca2+ levels induced by aberrant Ca2+ entry by overexpression of SARAF, a negative regulator of SOCE, promotes hypertrophy at least in part through mTORC1 hyperactivation [35].